Fractyl Health, Inc. (GUTS)
(Delayed Data from NSDQ)
$4.27 USD
-0.16 (-3.61%)
Updated Jun 28, 2024 04:00 PM ET
After-Market: $4.23 -0.04 (-0.94%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
GUTS 4.27 -0.16(-3.61%)
Will GUTS be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for GUTS based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for GUTS
Bank of America Securities Reaffirms Their Buy Rating on Fractyl Health, Inc. (GUTS)
Fractyl Health price target lowered by $4 at BofA, here's why
Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day
Fractyl Health Updates Clinical Studies and Corporate Slides
Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates